Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists

Bioorg Med Chem Lett. 2011 May 15;21(10):2806-11. doi: 10.1016/j.bmcl.2011.03.107. Epub 2011 Apr 5.

Abstract

Multiple regions of the 3-oxazolidinedione-6-naphthyl-pyridinone series identified via high throughput screening were explored. SAR studies of these regions including the left-hand side oxazolidinedione moiety, α-substituent on the oxazolidinedione ring, central pyridinone core, and substituents on the central pyridinone core led to the discovery of potent EP(3) receptor antagonists such as compound 29 which possesses outstanding rat pharmacokinetic properties. Synthesis and SAR of these novel compounds and DMPK properties of representative compounds are discussed.

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Humans
  • Molecular Structure
  • Oxazoles / chemical synthesis*
  • Oxazoles / chemistry
  • Oxazoles / pharmacology
  • Protein Binding / drug effects
  • Pyridones / chemical synthesis*
  • Pyridones / chemistry
  • Pyridones / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Prostaglandin E, EP3 Subtype / antagonists & inhibitors*
  • Receptors, Prostaglandin E, EP3 Subtype / chemistry
  • Structure-Activity Relationship

Substances

  • Oxazoles
  • Pyridones
  • Receptors, Prostaglandin E, EP3 Subtype